Site specific dosing of a BTK inhibitor

• 收藏
• 分享

专利权人:

Principia Biopharma Inc.

发明人:

Nunn, Philip,Berner, Bret,Masjedizadeh, Mohammad

申请号：

AU2015371254

公开号：

AU2015371254A1

申请日:

2015.12.23

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

Disclosed herein are formulations and methods of site specific administration of Compound (I) or a pharmaceutically acceptable salt thereof. Compound (I) is a potent BTK inhibitor and hence can be useful for the treatment of diseases such as cancer, autoimmune, and inflammatory diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/